PepGen Inc. (PEPG)
2.47
+0.15
(+6.47%)
USD |
NASDAQ |
Nov 06, 16:00
2.51
+0.04
(+1.62%)
After-Hours: 20:00
PepGen Total Long Term Debt (Quarterly) : 12.86M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.86M |
| March 31, 2026 | 13.35M |
| December 31, 2025 | 13.82M |
| September 30, 2025 | 14.28M |
| June 30, 2025 | 14.72M |
| March 31, 2025 | 15.16M |
| December 31, 2024 | 15.57M |
| September 30, 2024 | 15.97M |
| June 30, 2024 | 16.36M |
| March 31, 2024 | 16.74M |
| December 31, 2023 | 17.10M |
| September 30, 2023 | 17.45M |
| Date | Value |
|---|---|
| June 30, 2023 | 17.86M |
| March 31, 2023 | 18.17M |
| December 31, 2022 | 18.98M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 0.984M |
| IRulya Therapeutics, Inc. | 0.00 |
| Q32 Bio, Inc. | 4.364M |
| Bridgebio Oncology Therapeutics, Inc. | 1.96M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |